gliotoxin has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadelis, MM; Castro, A; Chau, CH; Cook, KM; Copp, BR; Figg, WD; Goey, AK; Grkovic, T; Gustafson, KR; Henrich, CJ; McKee, TC; McMahon, JB; Ransom, TR; Sissung, TM; Venzon, DJ | 1 |
Campbell, TJ; Chau, CH; Cook, KM; Figg, WD; Holly, AJ; Liewehr, DJ; Pisle, ST; Price, DK; Reece, KM; Richardson, ED; Venzon, DJ | 1 |
2 other study(ies) available for gliotoxin and Angiogenesis, Pathologic
Article | Year |
---|---|
Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
Topics: Alkaloids; Animals; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; E1A-Associated p300 Protein; HCT116 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Marine Biology; Molecular Structure; Neovascularization, Pathologic; Porifera; Prostatic Neoplasms; Pyrroloiminoquinones; Quinones; Spiro Compounds; Thiazepines; Vascular Endothelial Growth Factor A | 2016 |
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Disulfides; DNA-Binding Proteins; E1A-Associated p300 Protein; Endothelial Cells; Gene Expression Regulation, Neoplastic; Gliotoxin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indole Alkaloids; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphopyruvate Hydratase; Piperazines; Prostatic Neoplasms; Protein Binding; Rats; RNA, Messenger; Signal Transduction; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A | 2014 |